Molecular Partners Reports 'Encouraging' Initial Data From Phase 1/2a Trial of MP0533
Molecular Partners Reports 'Encouraging' Initial Data From Phase 1/2a Trial of MP0533
Molecular Partners 報告了 MP0533 的 1/2a 期試驗中 “令人鼓舞” 的初步數據
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊